AC Immune S.A.
ACIU · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $244,335 | $356,039 | $157,522 | $338,240 |
| - Cash | $36,275 | $78,494 | $31,586 | $82,216 |
| + Debt | $5,427 | $3,497 | $2,801 | $2,910 |
| Enterprise Value | $213,487 | $281,042 | $128,737 | $258,934 |
| Revenue | $27,309 | $14,801 | $3,935 | $0 |
| % Growth | 84.5% | 276.1% | – | – |
| Gross Profit | -$35,261 | -$39,805 | $3,935 | $0 |
| % Margin | -129.1% | -268.9% | 100% | – |
| EBITDA | -$48,618 | -$51,832 | -$68,026 | -$70,006 |
| % Margin | -178% | -350.2% | -1,728.7% | – |
| Net Income | -$50,916 | -$54,233 | -$70,753 | -$72,996 |
| % Margin | -186.4% | -366.4% | -1,798% | – |
| EPS Diluted | -0.51 | -0.64 | -0.85 | -0.97 |
| % Growth | 20.3% | 24.7% | 12.4% | – |
| Operating Cash Flow | $65,842 | -$60,408 | -$73,568 | -$65,689 |
| Capital Expenditures | -$576 | -$801 | -$1,239 | -$2,635 |
| Free Cash Flow | $65,266 | -$61,209 | -$74,807 | -$68,324 |